CLINICAL TRIALS OF ANTIFUNGAL THERAPIES NIH GUIDE, Volume 23, Number 39, November 4, 1994 RFP AVAILABLE: NIH-NIAID-DMID-96-04 P.T. 34 Keywords: Clinical Trial Fungal Diseases+ National Institute of Allergy and Infectious Diseases The Bacteriology and Mycology Branch, Division of Microbiology and Infectious Diseases of the National Institute of Allergy and Infectious Diseases (NIAID) has a requirement for a collaborative clinical trials group for serious fungal infections to include those caused by Candida, Aspergillus, Cryptococcus, Coccidioides, Histoplasma, and Blastomyces. A clinical trials program will be designed to facilitate advances in antifungal therapy by rigorously determining the efficacy and safety of new therapeutic regimens for serious mycotic diseases. The program will be driven by a scientific agenda with proposed studies that will address the most important gaps in treatment, the appropriate fungal pathogens and risk groups. Risk groups of emphasis are HIV infected patients, neutropenic cancer patients, bone marrow and organ transplant patients, and surgical trauma patients. Provision should also be made for the key management problems with the endemic mycoses in immunocompetent hosts. This group will conduct Phase II and Phase III clinical trials to evaluate antifungal therapies including, but not limited to new agents, formulations, dosing regimens, drug combinations, as well as immunebased therapeutics. Request for Proposals (RFP) No. NIH-NIAID-DMID-96-04 will be available on or about November 15, 1994. Responses will be due at close of business February 15, 1995. It is anticipated that one, cost reimbursement, completion contract will be awarded for a period of five years. All interested offerors are encouraged to submit a proposal. Any responsible offeror may submit a proposal that will be considered by the Government. INQUIRIES To receive a copy of the RFP, supply this office with two self- addressed mailing labels. Telephone inquiries will not be honored and all inquiries must be in writing and addressed to: Mr. Anthony J. Murray Contract Management Branch National Institute of Allergy and Infectious Diseases 6003 Executive Boulevard MSC 7610 Solar Building, Room 3C07 Bethesda, MD 20892-7610 Interested organizations should request either a streamlined or full RFP package. If no selection is made, a streamlined version of the RFP will be provided, which includes only the Statement of Work, deliverable and reporting requirements, special requirements and mandatory qualifications, if any, and the Technical Evaluation Criteria. After examination of the abbreviated document, any organization interested in responding to the RFP must request the entire RFP in writing or by FAX request (301) 480-5253. This advertisement does not commit the Government to award a contract. .
Return to NIH Guide Main Index
Office of Extramural Research (OER) |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
Department of Health and Human Services (HHS) |
||||||||
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files. |